Reddit Posts
Microcaps have outperformed the S&P for 12 months straight
26 MARCH 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY ?
Momentum And Asymmetry: ADMA, RIGL Strength; MYNZ As Spec Swing
$QSI Poised for a November Surge: Strategic Moves with HUGE CASH balance and a Looming Buyout
Alright regards buckle up, we've OPEN the door now we do a value play with $NUVB
Biotech's Been Ice Cold — But One Stock Surges on FDA Approval, Another Shows Subtle Strength
Biotech's Been Ice Cold — But One Stock Surges on FDA Approval, Another Shows Subtle Strength
Biotech's Been Ice Cold — But One Stock Surges on FDA Approval, Another Shows Subtle Strength
Stocks in the healthcare sector to look at
ADMA stock gains as guidance exceeds consensus (NASDAQ:ADMA)
$ADMA tooooo the moon !! Who’s with me !!!
$ADMA I think is the new good game
$ADMA plasma I think is the new good game
I was right ADMA did move. Hopefully mods give me cred
$ADMA made its first ever gross profits. Should be fun!
Anyone here like ADMA? Seems to be climbing daily and ER wasn't to bad.
insiders just bought 580k shares of $ADMA
$ADMA going up on low volume after an offering. Anyone think it's a good play for a squeeze?
Why did $ADMA run after the offering? Anyone know a lot about this company? Still trying to dig up the facts.
ADMA Biologics - No Shorts Available
ADMA Biologics - NO SHORTS AVAILABLE
ADMA Biologics - No Shorts Available
ADMA -I told you big news was coming !!! FDA APPROVAL 🩸
ADMA Biologics (ADMA) - Overlooked and Undervalued with a Possible Buyout Looming - ~11% of float shorted.
ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection
I yolo'd on ADMA biologics and gave been completely wrecked. On the bright side, I now have enough loss porn to make a post about it ;)
$ADMA is ≈ $1.70, yet SIX (6) analysts cover it (All Buy or Strong Buy) & I have an academic research background and here is my DD summary & context for what it is worth.
ADMA 🚀🚀🚀 MIGHT BE SKYROCKETING BEFORE YOU REALIZE IT
$ADMA being shorted into oblivion for their open ATM. Shorts getting greedy
Full ADMA biologics DD and Evaluation from a senior accounting student. This is an opinion, not advice. If you have questions make a comment and I'll try to answer it.
ADMA biologics announced some big improvements to their manufacturing plant in May of last year which require FDA approvals. The company has approved drugs and has been on a sharp revenue ramp for the past year. Increasing production capacity by 50% should make one hell of a catalyst. 🚀🚀 🚀
ADMA Biologics...Rated a “ BUY”. Trading in the mid 2’s...Price Target is $7.76
Mentions
ADMA | ADMA Biologics - Current Price: $11.09 - Market Cap: ~$2.5B - Bull Target (12–18m): $16–$18 - Bear Target: $8.50–$9.25 - Upside: +44% to +62% - Downside: -17% to -23% - Reward-to-Risk: ~2.6:1 🟢 - Success Probability: 65% - Expected ROI: ~+24% - Forward P/E: ~12–14x 🟢 - Debt-to-Equity: ~0.48 - Cash: $136M - Total Debt: ~$197M - Dividend Yield: 0% - FY2026 Revenue Guidance: $530M–$560M - FY2026 Adjusted Net Income: $170M–$200M 🟢 - FY2026 Adjusted EBITDA: $265M–$300M 🟢 - Q2 Revenue: $124.4M - Q2 GAAP Net Income: $37.8M, +11% YoY - Q2 Gross Margin: 69% vs. 55% YoY 🟢 - ASCENIV Revenue: $102.9M, +24% YoY 🟢 - Share Buybacks: ~5.3% of shares repurchased in H1 2026 🟢 - Price Trend: Recovering, but still well below previous highs 🟡 - Risk: Moderate-High - Conviction: 7/10 - Grade: B+ ADMA manufactures specialty plasma-derived biologics, led by ASCENIV, and the underlying business is considerably stronger than the stock's earlier volatility suggests. Rapid ASCENIV growth, expanding margins, real profitability, strong cash generation, aggressive buybacks and roughly 2.6:1 reward-to-risk make $11.09 a legitimate B+ setup, with competitive pressure in the broader immune-globulin market keeping it below A-range for me.
B (Barrick Mining), EXLS (EXL Services), INTU (Intuit), ZTU (Zoetis), and ADMA
Just loaded ADMA calls on margin. Go broke or die trying.
If this gets 1 upvote I will yolo 10k into puts on: META CRWD RCL NET CRM PLTR SLM ADMA CRWV
ADMA got fucked hard by a short report from Culper Research. Those dickheads love to bear raid good companies.
I'll preface this with saying penny stocks are time consuming. One of my friends makes about the same income as me for the past 10 years. All he's done is DCA through VOO And VTI. He's ahead financially in his investments. And he's spent WAY LESS TIME than I have. But, I enjoy learning about companies and picking some stocks as well as investing into ETF's like ones that track the S&P500. If you decide to buy penny stocks, I'd recommend only buying companies you understand and see the potential in. This way, you can gain personal value learning about companies, industries, financials, etc. And if you lose some $ on a bet, you still personally retain value from the experience. I've lost my shirt on a ton of penny stocks, but overall my penny stock portfolio has outperformed the S&P500 over a 5 year period. (At one point in that same 5 year period, it was down like 75% as these things can be super volatile.) I'll give you some examples. I used to work in marketing and one of my clients had a blood plasma business. I found this penny stock back in the day called ADMA. They're involved in the blood plasma industry... read about them, liked their business and decided to invest/gamble in shares. Now it's up 500%+. I sold off enough ADMA to break even + profit some, then left the rest of the shares to ride. About a year and a half ago, I was looking for an alternative to NVIDIA. I missed so many NVIDIA buying opportunities and still felt it was overvalued - turns out I was wrong again. Any way, I started learning more about quantum computing. There were some stocks priced in the $40 range like IONQ... so I found a quantum computing ETF that included other holdings, which, at the time were Rigetti and D Wave. Those were close to a buck, so I bought a handful. Then they skyrocketed 1,000%+. All that being said, what I've found on penny stock forums in Reddit is some of the DD's are basically sales pitches for a path towards a titanic iceberg. If you read those, just do your own DD and make sure you truly think it's a good buy. There's some good DD penny stock posts as well. I've found several good penny stocks by reading the DD's + doing my own research. Have fun!
Well I'm going with in order of position size; Meta Knsl Meli NVO (down 9% and holding for now) ADMA CRM Amazon Zeta Global I expect that grow my position in Amazon throughout the year
I am looking at the ADMA and the RSI. And I stand corrected on RKLB. It is not yet overbought on the RSI but in an area close enough to it that I would not buy. I would hold, but not buy. But each to their own. I was referring to the ADMA. But yes, if you only use the RSI you are correct. But again not where I would buy. I was actually answering the OPs question on buying. So you’re a buyer of both the ones the OP mentioned?
I only started tracking my buys about 6 months ago but in those 6 months had a few that went really well... AMD(+85%) , GOOG(+98%), FSLR(+80%), ASML(+63%) , VIST(+40%) , SEZL(28%) , ADMA(29%) to name a few... However... 2 of my picks went badly lol: CMG(-25%) , TTD( -20%) (I have to be honest and show my losing picks too, its not always sunshine haha. Study your bad picks as much if not MORE than your wins as you can often learn a lot more from them)
ADMA had solid earnings and is down this morning. Easy 10% up from here in the next week.
ADMA, impressive earnings and very stable revenue making machine
I currently have 5 shares of ADMA I bought in 2022 at $2.73 a share, it’s not trading at $16 and has been increasing throughout the week, do I hold this long term or take the $70 profit and invest somewhere else? This may sound dumb but I’m young and just trying to learn.
Yessir...! And Long here, have 9000 shares with a $1.20 average... This has such great upside!!!! Reminds me of another 10+ bagger I had, ADMA!
#TLDR --- Ticker: XERS Direction: Up Prognosis: Buy shares, this is a 'get rich slow' scheme. Catalyst: About to hit profitability (Q3 earnings), similar setup to ADMA & CORT before they mooned. Price Target: $35 short-term, $70+ by 2030.
$ADMA is performing well today👀
Quantum-Si (QSI) has **publicly demonstrated post-translational modification (PTM) detection**, most notably the ability to distinguish between arginine modifications such as methylation (ADMA, SDMA) and citrullination using its single-molecule sequencing platform, marking one of the strongest concrete proofs of concept for PTM readout on a commercial system to date \[Quantum-Si, 2023a\]. The company’s **next-generation protein sequencing (NGPS) architecture**, which relies on kinetic binding signatures of recognizer molecules at the single-molecule level, is inherently suited to detecting PTMs because these chemical modifications alter local binding kinetics \[Reed et al., *Science*, 2022\]. Nonetheless, the **scope of PTM detection remains limited**: not all modification classes have been validated, and questions persist regarding generalizability, sensitivity, error rates, and throughput when applied to complex proteomes \[Quantum-Si, 2023b\]. As such, QSI currently positions its platform as a **complementary tool to mass spectrometry** for proteoform and PTM discovery, rather than a direct replacement \[SelectScience, 2024\]. [Detection-of-arginine-post-translational-modifications-by-single-molecule-protein-sequencing-on-the-Quantum-Si-PlatinumTM-platform.pdf](https://www.quantum-si.com/wp-content/uploads/Detection-of-arginine-post-translational-modifications-by-single-molecule-protein-sequencing-on-the-Quantum-Si-PlatinumTM-platform.pdf)
I started a position not long after. Based on research its an obvious acquisition target. You seem very knowledgeable in biotech. Any big opportunities you see? I'm evaluating a few different commerical bios like TGTX, TARS, ADMA etc but don't really look at companies in phase1/2
i was also into SMCI and ADMA when similar problem happened. It ended up going well for me but as we all know the past doesn’t predict the future. God speed regard, see you in Valhalla or Wendy’s
Here’s a real example from my experience earlier this year. I had just bought into AMDA around 20ish, when in October news of a lawsuit hit the wires and it gapped down big, losing about -20% that day at its intraday low. I sold AMDA immediately for a loss. I took those remaining funds and bought that same day MSTR as it broke out of a long base at 179. MSTR rocketed to a high of 543. It’s at 385 now. ADMA is at 19 today.
US based pharma/bio will not be affected. Companies like ADMA and the like have zero tariff exposure. Do the research and find companies that are US based with no reliance on imports.
I use tools on the 4h and daily frame to give me Momentum/ADMA signals that a serious reversal is possible. I tested those on swing trades with 15m and 1h frames and they work "well enough".
In terms of total profit, VRNA. I think it was about a 9 bagger in 15 months. ADMA was about a 10xer in a similar time frame. HROW 7x in short time frame also. AGEN was the biggest money loser of my life, lost maybe 80% in two years.(lost 6 figures) Biotech is rough.
ADMA too if anyone’s been interested in getting a position
ADMA -I bought it at like 3.88 as a joke, still holding
Honestly, if you have a job, you could start investing $100 every week into a growth fund or any premium growth stocks you find with research. You're still young so you can risk investing in growth. $35 is really nothing to work with unless you're trying to do some sort of trading challenge. But some stocks I could recommend you to do research into are NBIS, LUNR, ABCL, ADMA, MVST, DNN, MBOT. Also, don't assume that the lower price the stock is the better risk you have. You can ask AI to help you research into industries also if you want, make sure to tell it to take into account current economic/political stuff and use both financial and technical analysis. It won't be 100% accurate of course and you should do your own due diligence. You have a long way to go, at least learn the basics of financials for valuation and technicals for the right time to buy.
I was bagholder of HIMS and ADMA. Wish I had continued to bag hold instead of dumping those for a loss.
I have one share I bought at $483 ;( ADMA (up 323%) RKLB (up 183%) Relatively small positions in all 3 though so only up $700 total on them, and sadly LUNR was the space stock i doubled down on 🤡
ADMA earnings call holding music is Jack and Diane Little ditty...
ADMA earnings could be good CEO doing a fireside chat the day after, wtf, cant be reporting bad news
ADMA earnings could be good CEO doing a fireside chat the day after, wtf, cant be reporting bad news
IOVA just bleeds money, they want more share dilution to fund their expansion offerings in EU and Canadian markets. Except they have to have to build up their own clinics as per the FDA treatment rules. They still spend 3x the capital in liabilities over retained earnings. For comparison, $ADMA started in the same position as IOVA but they don’t need to expand and produce 1.3x earnings with high margins. They are net debt free on the books. The overall way to invest in Biomed is simple, just buy profitable Biomeds, not cash burning trash.
Yeah, feels like I'm seeing a lot of "cheap" fundamentals in that space right now. HRMY and ADMA are both on my radar. Opened a starter and looking more into them.
If you sell it, it'll be the new worst decision of your life. Just hold it and dca. It'll go back up eventually, might take a year or two though. Almost every stock I've ever sold for a loss I regret. I would have doubled my money if I didn't sell GEV, SPOT, RDDT, ADMA, HIMS. But I lost money or broke even on most of those
Might I interest you in... ADMA. I promise you will be holding that bag indefinitely
No, not if you pick quality companies or funds. I have had Costco, Nvidia, Walmart, QQQM for a long time and not had to sell once. If you pick little not very well known places then yes, you will sell frequently. In 3 years I have only sold off 3 stocks that followed that rule, MPW, SFM and ADMA.
When I first opened a brokerage account i think in 2020 one of my first stocks I bought was a biologic company ADMA didn't even now what the heck I was doing. Just randomly decided to buy 1500 shares of a penny stock at 1.30 . Sold at 20.00 talk about beginners luck. Boy was hooked on penny stock gambling after that.
Found ADMA on here when it was 1.30
If you're interested in knowing what LEAPS am holding, it's HIMS, HOOD, LUNR (cause of moon launch, hype strong but I recognize fundamentals are lousy), ADMA, S, ACHR, and long dated calls on DKNG (Feb.) and KULR (June). I have no crypto plays but KULR added lots of BTC so could be a joke or could have MSTR like effect regardless I consider it my crypto play)
Safe long calls on $ADMA. Have held since $18.40 will ride to $22.00
You guys are making my +900% position in ADMA very nervous with the way you're talking
I bought ADMA at $0.50 a couple years back. I’m still riding that high.
got in ADMA at $1.30 thanks to reddit pennystocks or wsb (can't remember which one i found it on!)
Half SMCI, half SOUN half ADMA, MRNA and GPCR. All regarded.
ADMA Bought in spring of 2021 for 2.xx per share
ADMA Biologics, keep an eye out
\- ADMA Biologics (ADMA \- Shift4 Payments (FOUR) \- Axon Enterprise (AXON) \- Amazon (AMZN) (Bought this Friday)
I'm still in HIMS, ADMA I was only selling spreads on. SOFI I sold at 8 dollars sadly 😓
I'm in CRMD and ADMA. Both have room to run still and are good acquisition targets, IMO.
Want to make more cash? ADMA is it.
Not listed but ADMA 11/7. They're now a revenue generating machine.
Bought LEAPS on ADMA and S, these two fundamentally are rock solid
20-30% i def start taking profits. and let the rest ride. but there are exceptions. i had planned on taking 20-30 from my ADMA profits, but its price suddenly dropped 20% so i sold it all. made my money back and a 70% profit,
Worked great for me with Meta (+270%) and ADMA (+700%). Trading != investing
I have ADMA 22c’s that i hope don’t expire worthless
UPST and ADMA calls. Yes, I made money. Still holding.
ADMA could break out anytime down at the time of the post but hitting new highs every other day
Dell & PLTR made SP500 inclusion but the big names who made SP400 and SP600 are worth checking out which most don't consider. PSN (military/defense), FN (fabrication), which look promising, and YOU & ADMA are looking like potential growth stories with growing EPS each quarter.
ADMA... firing on all cylinders and joining S&P Small Cap 600
I rode out ADMA for 4 years underwater. So glad I held out.
I’ve got 5 calls with 19.50 strikes Dec 20 exp, not really an IV crush just a NDQ pullback not worried whatsoever. IV has always picked up a lot pre earnings. Currently sits around avg at 57%-67% which hasn’t really changed much. ADMA is one of those stocks where if you buy the dip you practically cannot lose.
Between my myself, father and Uncle we have about 5.5k shares, been holding since $9.50, I also bought 5 calls with 19.50 strikes exp Dec 20th, made a DD post on ADMA not too long ago that went through a thesis on why the company will still continue to grow. From what I’ve seen in the past activity patterns in the options chains is that the calls gain significantly more IV and volume pre earnings. I must admit, those $22 strikes are pretty aggressive going that deep OTM. However you should be relatively okay on your long expirations, ADMA should continue to chug its way along, the interest rate cuts will be a big W for the their balance sheets. I don’t think there’s any major need to panic, I would suggest holding and not closing any positions, but if you’re up pre earnings I’d suggest taking a bit off of the table to manage risk.
I have a few that really surprised me: ADMA 295% YTD SERV 260% FTAI 150% HWKN 70% UTHR 50% MPWR 50% ANET 50%
I bought a share in January 2023 for ~$483 and it's worth ~$881 now with reinvesting dividends :) (+79.56%) My 4th biggest G% except for ADMA (up 254.19% since January 2024) LUMN (up 89.13% since 2 weeks ago but I only bought one share so it's worth $6.02 lol) MRVL (up 86.14% since January 2023)
I think ADMA still has good days ahead, though it has run up 30% since my recommendation a month ago. I own a lot of it and personally i would not dream of selling a share until i get a compelling reason to do so. . It is a very solid and growing company and the owner has a significant personal stake. I would definitely hold ADMA at least through the next earnings call in November. As to HROW, probably not too late to get more. I see 40% annual growth for at least next 3 years, and if MELT-300 works out you can probably double that. Still one of the most underpriced equities I know. I think the next HROW earnings call will shock the world, just like the last one. Assuming market holds together I do not see how HROW does not hit 50 by EOY. glta
I'm in HROW only wish I put more in. Do you still see value in ADMA just taking a look at the chart it's run up a lot
Praying that ADMA will sky rocket by tomorrow
ADMA produces 3 FDA approved immunodeficiency drugs 2 of them are highly effective for treating even the most severely comorbidity conditioned patients with immunodeficiency. These are people who are persistently hospitalized, have little hope in life for stability and they have exhausted all other treatments which have not provided them immune support whatsoever. ADMA’s Ascentiv and Bivigam immunoglobulin drugs have quite literally changed their lives. If these drugs work for the patients they are, as the CEO reinstated “once it works for the patient they are taking the treatment for rest of their lives every 24-30 days”. In turn, Ascentiv and Bivigam produce guaranteed future revenues and profit growth as patients line up to receive this life changing treatment. Navi-B has also been great and effective for treating specifically Hepatitis, however it’s more niche in ADMA’s pipeline. Productions and in house collections centres: ADMA’s achieves this by operating with their own in house blood plasma collections centres across the East Coast of the US which targets and pays bonuses to donors with the highest antibody hyper immune systems and the lowest genetic antibiotic resistance. Additionally, they also collect and supply regular blood and plasma to clinics, hospitals, other drug manufacturers. With this information you can start to see how ADMA has tapped into a high value drug with multi-channel exponential growth revenue streams. Currently they have just eclipsed $100M in a single Q. The CEO has repeatedly broken down the numbers into simple for production capacity within drug revenues. They have capacity within their current Boca Raton FL manufacturing facility to produce peak drug manufacturing revenues of $1-$2B annually. Last Q reflected $100M, the worst problem that ADMA has is the best problem to have, they have more demand for their drug than they’re able to supply. The best part last Q earnings call was the report on ADMAlytics, using their efficiency streamlining AI ADMAlytics they have been able to identify method of a production yield enhancement which will produce +20% yields with current plasma supply for Ascentiv. They are currently in process for BLA approval through FDA application for this by next year. Great news all across the board and I have been buying the stock hand over fist before last Q and currently as it pushes all time highs. This is a stock that you buy in your Roth and forget about, they quite literally have a patent to print money.
Full port longs on ADMA. Fastest growing small cap biomed stock on the NYSE.
Well if you bought ADMA and DPST you’d be up. Unfortunately I’ve had to hedge my AVGO holdings since, I had though tech was going to be stagnant I guess the liquidity bubble in the Nasdaq needed to be relived of more pressure than I thought. bought SOXS last week to manage just under break even. Sold my inverse ETFs on Thursday and bought CONL To end the week up. DM for order fills
Did you even consider the time frame I’m talking about? I’m talking about future not past tense moron. Stagnant as of this period leading up to rate cuts, not in the past. The markets are clearly leaning towards low interest high profit sectors, ie bank stocks, low cap Biomeds that are debt leveraged and on the cusp of zero net debt and profitability. Don’t take my word for it, go look at the charts. DPST is up +49% in the past 5 days. ADMA is up +14% in the past 5 days. AVGO is down -1% over the past 5 days, NVDA is down nearly -4%. People lie, numbers don’t.
I sold my first ever call this morning. I held an ADMA 12.5c 7/19, got in at .30 and sold at .60. By market close it was at 1.00. I get the feeling, but I’ve lurked here enough to know that profit is profit and I doubled my money, and to not get greedy.
What would you define as medical tech? I agree that health care and medical in general is going to be profitable but what would you say falls into the category in your opinion? I’ve been looking at $ADMA $LGVN (since their recent FDA approval and $ESPR
HROW. Bet you never heard of it. Tied w ADMA for largest position.
1) the reason why I wanted these shares is because I had previously sold 500 ot the 3500 held. 2) im never going to buy 0DTE’s because the implied volatility even now is not sufficient to push a large margin on premiums returns, the volume on this stock, especially options are quite low, I can’t count on the fact that the stock will be at “x” price before earnings, there’s many factors. I’m basing this entirely on a technical term. Last quarter ADMA had rallied significantly, and subsequently had a $1.00 pullback before earnings, then as earnings approached the share price had risen back to a high. Yes it is possible that the $300 I made off of premiums selling $11.50 calls would’ve net more closer to my expiration on July 19th. But I had strategically placed them there to net the highest return on a potential (within my technical trading range) to return some profit while exercising. Given that I wanted more shares, and I would’ve shorted if it had gone down to my $10.50 range. But I had felt that the share price was going to continue to rally before a pullback, this is why I bought the calls. I’m also not looking to take on high risk, I’ll take a win where I can. I had also been on a live call with my broker to confirm that I wanted to exercise, since I had purchased the options the implied has gone up 50%, they had recommended to sell the options but I insisted on exercising, now I have the ability to stop loss and add a few hundred in profit to hedge before earnings in August. I am honestly thinking that with this profit I would be better off short hedging 5k and covering as soon as possible on the upside on the earnings call rather than writing covered calls.
It isn’t a normal approach to a hedge at all but it’s directionally bullish. I exercised because I’m in the money and I want the extra shares, I think ADMA will continue to grow this year. Just sold the other 5 options today at $12.40 SP for a couple hundred return. Regardless I think it will yield more because otherwise I was planning to hedge with my margin account and 5k with short sold shares and the cost of that plus cover is probably going to be more. I will be writing some covered calls this week if it get close to $13.00 to hedge a small amount. I’m trying to protect some small amount of downside pre earnings.
Ok that certainly makes sense to get the whole info out there. 1 ADMA 12.5c 7/19 @ $0.30 is what I bought.
Welcome! My first bit of advice is to include the full trade details when discussing a position. Even if it's just an offhand example, it's a good habit to get into, because you never know, some follow-up discussion might make the details relevant. Here's the standard notation: (-)N TICKER STRIKE(c or p) EXPIRATION @ $X.XX N = quantity, number of contracts/spreads, where a minus sign indicates sold to open TICKER = ADMA in your case STRIKE = the strike price, which you omitted from your comment (c or p) = to indicate a call or put, so if the strike was 12, you would write 12c for a call EXPIRATION = MM/DD, add the year if it isn't the current year $X.XX = premium paid/received, in per-share dollars, so $0.30 in your case Assuming it was the 12 strike for next month, that would be: 1 ADMA 12c 8/16 @ $0.30